...Thanks, everybody. Thanks for joining us this morning and making it to the third company day, fourth day overall of the conference here at Bank of America. So it's my pleasure to introduce the first session. We've got Emma Walmsley, CEO of GlaxoSmithKline. Also sitting in the front row here, also, Iain, the CFO as well. I think probably the best thing is, Emma, if you want to make some opening remarks, and then we'll dive straight into Q&A. As a reminder, if you've got a question, please raise your hand and just wait for the microphone, but I've got plenty otherwise. So over to you, Emma. Emma Natasha Walmsley ...